RCWMU
GILD icon

Rothschild & Co Wealth Management (UK)’s Gilead Sciences GILD Stock Holding History

Rothschild & Co Wealth Management (UK)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,500
Closed -$638K – 68
2015
Q1 		$638K Buy
+6,500
New +$660K 0.07% 26

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rothschild & Co Wealth Management (UK)'s GILD Position: Q2 2015 in Review

Rothschild & Co Wealth Management (UK) sold out of Gilead Sciences (GILD) in Q2 2015, closing a stake of 6,500 shares — an estimated $638K sold.

Rothschild & Co Wealth Management (UK) first reported a position in GILD in Q1 2015 and held it in 1 quarter. The position peaked at $638K in Q1 2015. 1,560 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

  • Rothschild & Co Wealth Management (UK) reported no remaining Gilead Sciences position as of Q2 2015 after selling out during the quarter.
  • Rothschild & Co Wealth Management (UK) sold 6,500 Gilead Sciences shares in Q2 2015, an estimated $638K.
  • Rothschild & Co Wealth Management (UK) first reported a position in Gilead Sciences in Q1 2015 and held it in 1 quarter.
  • Rothschild & Co Wealth Management (UK)'s Gilead Sciences position peaked at $638K in Q1 2015.
  • 1,560 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on Rothschild & Co Wealth Management (UK)'s 13F filing for Q2 2015, filed 19 Dec 2019.